keats complementary practice ltd
keats complementary practice ltd Company Information
Company Number
03932931
Website
www.keatshealth.co.ukRegistered Address
18a london road, enfield, middlesex, EN2 6EB
Industry
Other human health activities
Telephone
02083662300
Next Accounts Due
December 2025
Group Structure
View All
Shareholders
-0%
keats complementary practice ltd Estimated Valuation
Pomanda estimates the enterprise value of KEATS COMPLEMENTARY PRACTICE LTD at £38.8k based on a Turnover of £86.8k and 0.45x industry multiple (adjusted for size and gross margin).
keats complementary practice ltd Estimated Valuation
Pomanda estimates the enterprise value of KEATS COMPLEMENTARY PRACTICE LTD at £20.1k based on an EBITDA of £5.3k and a 3.77x industry multiple (adjusted for size and gross margin).
keats complementary practice ltd Estimated Valuation
Pomanda estimates the enterprise value of KEATS COMPLEMENTARY PRACTICE LTD at £28.5k based on Net Assets of £11.4k and 2.49x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Keats Complementary Practice Ltd Overview
Keats Complementary Practice Ltd is a live company located in middlesex, EN2 6EB with a Companies House number of 03932931. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2000, it's largest shareholder is unknown. Keats Complementary Practice Ltd is a mature, micro sized company, Pomanda has estimated its turnover at £86.8k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Keats Complementary Practice Ltd Health Check
Pomanda's financial health check has awarded Keats Complementary Practice Ltd a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
6 Weak
Size
annual sales of £86.8k, make it smaller than the average company (£583.4k)
- Keats Complementary Practice Ltd
£583.4k - Industry AVG
Growth
3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (7.2%)
- Keats Complementary Practice Ltd
7.2% - Industry AVG
Production
with a gross margin of 23.3%, this company has a higher cost of product (39.1%)
- Keats Complementary Practice Ltd
39.1% - Industry AVG
Profitability
an operating margin of 6.1% make it more profitable than the average company (5%)
- Keats Complementary Practice Ltd
5% - Industry AVG
Employees
with 3 employees, this is below the industry average (15)
3 - Keats Complementary Practice Ltd
15 - Industry AVG
Pay Structure
on an average salary of £25.4k, the company has an equivalent pay structure (£25.4k)
- Keats Complementary Practice Ltd
£25.4k - Industry AVG
Efficiency
resulting in sales per employee of £28.9k, this is less efficient (£44.9k)
- Keats Complementary Practice Ltd
£44.9k - Industry AVG
Debtor Days
it gets paid by customers after 37 days, this is later than average (21 days)
- Keats Complementary Practice Ltd
21 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Keats Complementary Practice Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Keats Complementary Practice Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Keats Complementary Practice Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 3.2%, this is a lower level of debt than the average (21.4%)
3.2% - Keats Complementary Practice Ltd
21.4% - Industry AVG
KEATS COMPLEMENTARY PRACTICE LTD financials
Keats Complementary Practice Ltd's latest turnover from March 2024 is estimated at £86.8 thousand and the company has net assets of £11.4 thousand. According to their latest financial statements, Keats Complementary Practice Ltd has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 3 | 3 | 4 | 1 | 1 | 1 | 1 | 1 | |||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 1,239 | 1,239 | 2,478 | 3,717 | 4,956 | 6,195 | 6,195 | 7,434 | 8,673 | 9,912 | 11,151 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 1,239 | 1,239 | 2,478 | 3,717 | 4,956 | 6,195 | 6,195 | 7,434 | 8,673 | 9,912 | 11,151 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 8,805 | 6,868 | 7,753 | 28,830 | 14,713 | 7,038 | 3,122 | 1,300 | 319 | 1,113 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,186 | 2,829 | 0 | 81 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 3,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 11,805 | 9,868 | 10,753 | 31,830 | 17,713 | 10,038 | 6,122 | 1,300 | 319 | 1,113 | 3,186 | 2,829 | 0 | 81 | 0 |
| total assets | 11,805 | 9,868 | 10,753 | 31,830 | 18,952 | 11,277 | 8,600 | 5,017 | 5,275 | 7,308 | 9,381 | 10,263 | 8,673 | 9,993 | 11,151 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 952 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 1,611 | 1,611 | 3,136 | 2,415 | 5,026 | 7,814 | 10,398 | 13,753 | 0 | 0 | 12,748 | 1,028 | 1,028 | 159 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 1,611 | 1,611 | 3,136 | 2,415 | 5,026 | 7,814 | 10,398 | 13,753 | 0 | 0 | 12,748 | 1,980 | 1,028 | 159 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 375 | 825 | 450 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,991 | 14,992 | 39,842 | 52,590 | 52,590 | 52,090 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 375 | 825 | 450 | 0 | 0 | 0 | 0 | 0 | 0 | 14,991 | 14,992 | 39,842 | 52,590 | 52,590 | 52,090 |
| total liabilities | 375 | 2,436 | 2,061 | 3,136 | 2,415 | 5,026 | 7,814 | 10,398 | 13,753 | 14,991 | 14,992 | 52,590 | 54,570 | 53,618 | 52,249 |
| net assets | 11,430 | 7,432 | 8,692 | 28,694 | 16,537 | 6,251 | 786 | -5,381 | -8,478 | -7,683 | -5,611 | -42,327 | -45,897 | -43,625 | -41,098 |
| total shareholders funds | 11,430 | 7,432 | 8,692 | 28,694 | 16,537 | 6,251 | 786 | -5,381 | -8,478 | -7,683 | -5,611 | -42,327 | -45,897 | -43,625 | -41,098 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,239 | 1,239 | 1,239 | 1,239 | 1,239 | |||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Tax | |||||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 1,937 | -885 | -21,077 | 14,117 | 7,675 | 6,916 | 1,822 | 981 | -794 | 1,113 | 0 | 0 | 0 | 0 | 0 |
| Creditors | -1,611 | 0 | -1,525 | 721 | -2,611 | -2,788 | -2,584 | -3,355 | 13,753 | 0 | -12,748 | 11,720 | 0 | 869 | 159 |
| Accruals and Deferred Income | -450 | 375 | 450 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,991 | -1 | -24,850 | -12,748 | 0 | 500 | 52,090 |
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,186 | 357 | 2,829 | -81 | 81 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -952 | 952 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,186 | 357 | 3,781 | -1,033 | 81 | 0 |
keats complementary practice ltd Credit Report and Business Information
Keats Complementary Practice Ltd Competitor Analysis
Perform a competitor analysis for keats complementary practice ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in EN2 area or any other competitors across 12 key performance metrics.
keats complementary practice ltd Ownership
KEATS COMPLEMENTARY PRACTICE LTD group structure
Keats Complementary Practice Ltd has no subsidiary companies.
Ultimate parent company
KEATS COMPLEMENTARY PRACTICE LTD
03932931
keats complementary practice ltd directors
Keats Complementary Practice Ltd currently has 3 directors. The longest serving directors include Ms Jacqueline Fraser (Feb 2000) and Mrs Rashmita Bedi (Jul 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Jacqueline Fraser | England | 61 years | Feb 2000 | - | Director |
| Mrs Rashmita Bedi | England | 59 years | Jul 2017 | - | Director |
| Ms Soraia Crystal | England | 63 years | Jul 2017 | - | Director |
P&L
March 2024turnover
86.8k
+38%
operating profit
5.3k
0%
gross margin
23.4%
+13.31%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
11.4k
+0.54%
total assets
11.8k
+0.2%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
keats complementary practice ltd company details
company number
03932931
Type
Private Ltd By Guarantee w/o Share Cap
industry
86900 - Other human health activities
incorporation date
February 2000
age
24
incorporated
UK
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
last accounts submitted
March 2024
address
18a london road, enfield, middlesex, EN2 6EB
accountant
-
auditor
-
keats complementary practice ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to keats complementary practice ltd.
keats complementary practice ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
